Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Tumor Mutational Burden and PD-L1 Expression in Hematologic Malignancies

Sean D Thomas, BS, Ah-Reum Jeong, MD, Patrick J Sakowski, AS, BA, Ethan S Sokol, PhD, Razelle Kurzrock, MD, Aaron M Goodman, MD

Blood (2020) 136 (Supplement 1): 15–17.

https://doi.org/10.1182/blood-2020-134375

Published: 2020

Journal Articles

A Prospective Initiative to Reduce Mucosal Barrier Injuries and Blood Stream Infections in Patients with Hematologic Malignancy Receiving Inpatient Chemotherapy

Daniel R Reed, MD, Katie E Ruefer, RN, Tanya D Thomas, RN, Erin L Harr, RN, Elizabeth R Daniels, RN, Jeremy M Sen, PharmD, BCOP, Michael K Keng, MD

Blood (2018) 132 (Supplement 1): 5896.

https://doi.org/10.1182/blood-2018-99-112598

Published: 2018

Journal Articles

The biology of nematode- and IL4Rα-dependent murine macrophage polarization in vivo as defined by RNA-Seq and targeted lipidomics

Graham D. Thomas, Dominik Rückerl, Benjamin H. Maskrey, Phillip D. Whitfield, Mark L. Blaxter, Judith E. Allen

Blood (2012) 120 (25): e93–e104.

https://doi.org/10.1182/blood-2012-07-442640

Published: 2012

Includes: Supplemental data

Journal Articles

Fcμ-Receptor (FcμR; TOSO/ FAIM3 ) Mediated Internalization of Antibody-Drug Conjugates: A Novel Approach to Selectively Target Chronic Lymphocytic Leukemia Cells

Berengere Vire, Ph.D., Alexandre David, Ph.D., Joshua D Thomas, Ph.D., Terrence R Burke, Jr., Ph.D., Christoph Rader, Ph.D., Adrian Wiestner, MD, PhD

Blood (2011) 118 (21): 734.

https://doi.org/10.1182/blood.V118.21.734.734

Published: 2011

Journal Articles

Antiphospholipid Antibodies Promote Leukocyte-Endothelial Cell Adhesion by Antagonizing Endothelial NO Synthase Via b2GPI and ApoER2.

Cristina Tarango, MD, Sangeetha Ramesh, PhD, Craig N. Morrell, DVM, PhD, Gail D. Thomas, PHD, Guillermina Girardi, PhD, Jane Salmon, MD, Ivan S. Yuhanna, Joachim Herz, PhD, Philip Thorpe, PhD, Philip Shaul, MD, Chieko Mineo, PhD

Blood (2009) 114 (22): 3039.

https://doi.org/10.1182/blood.V114.22.3039.3039

Published: 2009

Journal Articles

α-Enolase Is the c-myc Promoter-Binding Protein.

Donald M. Miller, MD, PhD, Hunter Campbell, Shelia D. Thomas, MS, Kara C. Sedoris, PhD

Blood (2007) 110 (11): 4075.

https://doi.org/10.1182/blood.V110.11.4075.4075

Published: 2007

Journal Articles

Weighted Prognostic Models for Survival in Untreated and Previously Treated Patients with CLL.

William G. Wierda, MD, PhD, S. OBrien, MD, X. Wang, MS, A. Ferrajoli, MD, S. Faderl, MD, D. Thomas, MD, F. Ravandi, MD, K. Do, PhD, H. Kantarjian, MD, S. Lerner, MS, M. Keating, MD

Blood (2005) 106 (11): 5012.

https://doi.org/10.1182/blood.V106.11.5012.5012

Published: 2005

Journal Articles

Serum Beta-2 Microglobulin: The Universal Independent Prognostic Factor for Patients with CLL.

William G. Wierda, MD, PhD, X. Wang, MS, S. OBrien, MD, S. Faderl, MD, A. Ferrajoli, MD, D. Thomas, MD, F. Ravandi, MD, J. Cortes, MD, F. Giles, MD, C. Koller, MD, H. Kantarjian, MD, S. Lerner, MS, M. Keating, MB BS

Blood (2005) 106 (11): 5018.

https://doi.org/10.1182/blood.V106.11.5018.5018

Published: 2005

Journal Articles

Salvage Therapy with Combined Cyclophosphamide (C), Fludarabine (F), Alemtuzumab (A), and Rituximab (R) (CFAR) for Heavily Pre-Treated Patients with CLL.

William G. Wierda, MD, PhD, S. OBrien, MD, A. Ferrajoli, MD, S. Faderl, MD, C. Koller, MD, F. Giles, MD, J. Cortes, MD, D. Thomas, MD, F. Ravandi, MD, G. Garcia-Manero, MD, M. Andreeff, MD, S. Lerner, MS, H. Kantarjian, MD, M. Keating, MD

Blood (2005) 106 (11): 719.

https://doi.org/10.1182/blood.V106.11.719.719

Published: 2005

Journal Articles

Treatment of Established Human Graft-Versus-Host Disease by Antithymocyte Globulin

R. Storb, M.D., E. Gluckman, M.D., E. D. Thomas, M.D., C. D. Buckner, M.D., R. A. Cliff, F.I.M.L.T., A. Fefer, M.D., H. Glucksberg, M.D., T. C. Graham, F. L. Johnson, M.D., K. G. Lerner, M.D., P. E. Neiman, M.D., H. Ochs, M.D.

Blood (1974) 44 (1): 57–75.

https://doi.org/10.1182/blood.V44.1.57.57

Published: 1974

Journal Articles

Allogeneic Marrow Grafting for Treatment of Aplastic Anemia

R. Storb, M.D., E. D. Thomas, M.D., C. D. Buckner, M.D., R. A. Clift, F.I.M.L.T., F. L. Johnson, M.D., A. Fefer, M.D., H. Glucksberg, M.D., E. R. Giblett, M.D., K. G. Lerner, M.D., P. Neiman, M.D.

Blood (1974) 43 (2): 157–180.

https://doi.org/10.1182/blood.V43.2.157.157

Published: 1974

Journal Articles

Pancytopenia and Leukemia in Hodgkin’s Disease: Report of Three Cases

P. L. Weiden, M.D., K. G. Lerner, M.D., A. Gerdes, M.D., J. D. Heywood, M.D., A. Fefer, M.D., E. D. Thomas, M.D.

Blood (1973) 42 (4): 571–577.

https://doi.org/10.1182/blood.V42.4.571.571

Published: 1973

Journal Articles

Treatment of Established Graft-Versus-Host Disease in Dogs by Antithymocyte Serum or Prednisone

R. Storb, M.D., H. J. Kolb, M.D., T. C. Graham, H. Kolb, M.D., P. L. Weiden, M.D., E. D. Thomas, M.D.

Blood (1973) 42 (4): 601–609.

https://doi.org/10.1182/blood.V42.4.601.601

Published: 1973

Journal Articles

Allogeneic Marrow Grafting for Hematologic Malignancy Using HL-A Matched Donor-Recipient Sibling Pairs

E. D. THOMAS, M.D., C. D. BUCKNER, M.D., R. H. RUDOLPH, M.D., A. FEFER, M.D., R. STORB, M.D., P. E. NEIMAN, M.D., J. I. BRYANT, R. L. CHARD, M.D., R. A. CLIFT, F.I.M.L.T., R. B. EPSTEIN, M.D., P. J. FIALKOW, M.D., D. D. FUNK, M.D., E. R. GIBLETT, M.D., K. G. LERNER, M.D., F. A. REYNOLDS, M.D., S. SLICHTER, M.D.

Blood (1971) 38 (3): 267–287.

https://doi.org/10.1182/blood.V38.3.267.267

Published: 1971

Journal Articles

Brief Report: Transplantation of Allogeneic Canine Bone Marrow Stored at -80 C. in Dimethyl Sulfoxide

R. STORB, M.D., R. B. EPSTEIN, M.D., R. F. LE BLOND, R. H. RUDOLPH, M.D., E. D. THOMAS, M.D.

Blood (1969) 33 (6): 918–923.

https://doi.org/10.1182/blood.V33.6.918.918

Published: 1969

Journal Articles

Brief Note: Marrow Repopulating Ability of Peripheral Blood Cells Compared to Thoracic Duct Cells

R. STORB, M.D., R. B. EPSTEIN, M.D., E. D. THOMAS, M.D.

Blood (1968) 32 (4): 662–667.

https://doi.org/10.1182/blood.V32.4.662.662

Published: 1968

Journal Articles

Treatment of Chronic Lymphocytic Leukemia by Extracorporeal Irradiation

R. STORB, M.D., R. B. EPSTEIN, M.D., C. D. BUCKNER, M.D., E. D. THOMAS, M.D.

Blood (1968) 31 (4): 490–502.

https://doi.org/10.1182/blood.V31.4.490.490

Published: 1968

Journal Articles

Marrow Engraftment by Allogeneic Leukocytes in Lethally Irradiated Dogs

R. STORB, M.D., R. B. EPSTEIN, M.D., H. RAGDE, M.D., J. BRYANT, B.A., E. D. THOMAS, M.D.

Blood (1967) 30 (6): 805–811.

https://doi.org/10.1182/blood.V30.6.805.805

Published: 1967

Journal Articles

Allogeneic Marrow Engraftment by Cross Circulation in Lethally Irradiated Dogs

R. B. EPSTEIN, M.D., T. C. GRAHAM, C. D. BUCKNER, M.D., J. BRYANT, B.S., E. D. THOMAS, M.D.

Blood (1966) 28 (5): 692–707.

https://doi.org/10.1182/blood.V28.5.692.692

Published: 1966

Journal Articles

In Vitro Studies of Erythropoiesis : I. The Effect of Normal Serum on Heme Synthesis and Oxygen Consumption by Bone Marrow

E. D. THOMAS

Blood (1955) 10 (6): 600–611.

https://doi.org/10.1182/blood.V10.6.600.600

Published: 1955

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Tumor Mutational Burden and PD-L1 Expression in Hematologic Malignancies

A Prospective Initiative to Reduce Mucosal Barrier Injuries and Blood Stream Infections in Patients with Hematologic Malignancy Receiving Inpatient Chemotherapy

The biology of nematode- and IL4Rα-dependent murine macrophage polarization in vivo as defined by RNA-Seq and targeted lipidomics

Fcμ-Receptor (FcμR; TOSO/ FAIM3 ) Mediated Internalization of Antibody-Drug Conjugates: A Novel Approach to Selectively Target Chronic Lymphocytic Leukemia Cells

Antiphospholipid Antibodies Promote Leukocyte-Endothelial Cell Adhesion by Antagonizing Endothelial NO Synthase Via b2GPI and ApoER2.

α-Enolase Is the c-myc Promoter-Binding Protein.

Weighted Prognostic Models for Survival in Untreated and Previously Treated Patients with CLL.

Serum Beta-2 Microglobulin: The Universal Independent Prognostic Factor for Patients with CLL.

Salvage Therapy with Combined Cyclophosphamide (C), Fludarabine (F), Alemtuzumab (A), and Rituximab (R) (CFAR) for Heavily Pre-Treated Patients with CLL.

Treatment of Established Human Graft-Versus-Host Disease by Antithymocyte Globulin

Allogeneic Marrow Grafting for Treatment of Aplastic Anemia

Pancytopenia and Leukemia in Hodgkin’s Disease: Report of Three Cases

Treatment of Established Graft-Versus-Host Disease in Dogs by Antithymocyte Serum or Prednisone

Allogeneic Marrow Grafting for Hematologic Malignancy Using HL-A Matched Donor-Recipient Sibling Pairs

Brief Report: Transplantation of Allogeneic Canine Bone Marrow Stored at -80 C. in Dimethyl Sulfoxide

Brief Note: Marrow Repopulating Ability of Peripheral Blood Cells Compared to Thoracic Duct Cells

Treatment of Chronic Lymphocytic Leukemia by Extracorporeal Irradiation

Marrow Engraftment by Allogeneic Leukocytes in Lethally Irradiated Dogs

Allogeneic Marrow Engraftment by Cross Circulation in Lethally Irradiated Dogs

In Vitro Studies of Erythropoiesis : I. The Effect of Normal Serum on Heme Synthesis and Oxygen Consumption by Bone Marrow

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only